NCT05910307 Synovial Sarcoma Registry / Biospecimen Repository
| NCT ID | NCT05910307 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Synovial Sarcoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-06-12 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-06-12 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes for patients with synovial sarcoma. The future research will involve various types of genetic testing. Participants will be asked to allow access to medical records and leftover tumor tissue and may be asked to give a blood or saliva sample. Participants will also be asked to completed questionnaires about their medical history and may be contacted every 6 to 12 months for updates for up to 10 years.
Eligibility Criteria
Inclusion Criteria: 1. Males or females of any age 2. Reported diagnosis of synovial sarcoma 3. Informed consent from subject (aged ≥18 years) or parent/guardian Exclusion Criteria: 1. Individuals with sarcomas that do not fit the definition of those considered for this registry 2. Individuals who are unwilling to participate 3. Individuals who are unwilling or unable to provide written consent
Contact & Investigator
Theodore Laetsch, MD
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT05910307 clinical trial?
This trial is open to participants of all sexes, studying Synovial Sarcoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05910307 currently recruiting?
Yes, NCT05910307 is actively recruiting participants. Contact the research team at gutsteinl1@chop.edu for enrollment information.
Where is the NCT05910307 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT05910307 clinical trial?
NCT05910307 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Theodore Laetsch, MD at Children's Hospital of Philadelphia. The trial plans to enroll 1,000 participants.